SANUWAVE Health Receives Approval from The National Health Surveillance Agency (ANVISA) to Market dermaPACE to Treat Chronic ...
Plans for Immediate Commercial Launch via Established Joint Venture SUWANEE, GA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of patented PACE® technology …